Novel Central Nervous System (CNS)-Targeting Protease Inhibitors for Drug-Resistant HIV Infection and HIV-Associated CNS Complications

There is currently no specific therapeutics for the HIV-1-related central nervous system (CNS) complications. Here we report that three newly designed CNS-targeting HIV-1 protease inhibitors (PIs), GRL-083-13, GRL-084-13, and GRL-087-13, which contain a P1-3,5-bis-fluorophenyl or P1-para-monofluorop...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Amano, Masayuki, Salcedo-Gómez, Pedro Miguel, Yedidi, Ravikiran S., Zhao, Rui, Hayashi, Hironori, Hasegawa, Kazuya, Nakamura, Tomofumi, Martyr, Cuthbert D., Ghosh, Arun K., Mitsuya, Hiroaki
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2019
Matèries:
Antiviral Agents
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6591644/
https://ncbi.nlm.nih.gov/pubmed/31061155
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00466-19
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars